Rodman & Renshaw Starts Cytokinetics (CYTK) at Market Outperform
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $74.13 +0.93%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Rodman & Renshaw initiates coverage on Cytokinetics (NASDAQ: CYTK) with a Market Outperform. PT $4.00.
For more ratings news on Cytokinetics click here and for the rating history of Cytokinetics click here.
Shares of Cytokinetics closed at $1.22 yesterday.
For more ratings news on Cytokinetics click here and for the rating history of Cytokinetics click here.
Shares of Cytokinetics closed at $1.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
